fitc lectins Search Results


90
Carl Zeiss fitc-lea lectin
The CSF1R inhibitor PLX5622, but not PLX73086, crosses the blood–spinal cord barrier to deplete virtually all microglia. a – c Representative confocal images of CD11b and P2ry12 immunostainings showing the almost complete elimination of microglia in the spinal cord of naïve (uninjured) C57BL/6 mice after treatment with the CSF1R inhibitor PLX5622 compared to those fed PLX73086 or the control diet. Mice were killed after 21 days of treatment. d – h Quantification of microglia in the spinal cord of uninjured C57BL/6 mice treated with PLX5622, PLX73086 or the control diet ( d ), as well as at the lesion epicenter in Cx3cr1 creER :: R26 - TdT mice killed at 1 ( e ), 7 ( f ), and 14 ( g ) days post-injury (dpi) ( n = 4–5 mice per group/time point). i Quantification of the proportional area of spinal cord tissue permeable to <t>FITC-conjugated</t> <t>lectin</t> injected intravenously prior to tissue fixation. j Quantification of Ly6G + neutrophils at the lesion epicenter at day 1 post-SCI in mice treated with either PLX5622, PLX73086, or the control chow ( n = 4–5 per group). k Quantification of the number of granulo-myelomonocytic cells at the lesion epicenter at 7 and 14 dpi in Cx3cr1 creER :: R26-TdT :: LysM -eGFP mice treated with either PLX5622, PLX73086, or the control diet ( n = 4–5 mice per group/time point). For all injured mice, treatment was initiated 3 weeks before SCI and continued until sacrifice. Data are expressed as mean ± SEM. ** p < 0.01, *** p < 0.001, **** p < 0.0001, PLX5622 or 1 dpi compared to the control group; and && p < 0.01, &&&& p < 0.0001, PLX5622 compared with the PLX73086 group. Statistical analysis was performed using a one-way ( d – g, i , j ) or two-way ( k ) ANOVA followed by a Bonferroni’s post hoc test. Scale bar: ( a – c , in c ) 200 µm
Fitc Lea Lectin, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/pmc06355913-310-15-36?v=Carl+Zeiss
Average 90 stars, based on 1 article reviews
fitc-lea lectin - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Carl Zeiss fitc-conjugates lectins
The CSF1R inhibitor PLX5622, but not PLX73086, crosses the blood–spinal cord barrier to deplete virtually all microglia. a – c Representative confocal images of CD11b and P2ry12 immunostainings showing the almost complete elimination of microglia in the spinal cord of naïve (uninjured) C57BL/6 mice after treatment with the CSF1R inhibitor PLX5622 compared to those fed PLX73086 or the control diet. Mice were killed after 21 days of treatment. d – h Quantification of microglia in the spinal cord of uninjured C57BL/6 mice treated with PLX5622, PLX73086 or the control diet ( d ), as well as at the lesion epicenter in Cx3cr1 creER :: R26 - TdT mice killed at 1 ( e ), 7 ( f ), and 14 ( g ) days post-injury (dpi) ( n = 4–5 mice per group/time point). i Quantification of the proportional area of spinal cord tissue permeable to <t>FITC-conjugated</t> <t>lectin</t> injected intravenously prior to tissue fixation. j Quantification of Ly6G + neutrophils at the lesion epicenter at day 1 post-SCI in mice treated with either PLX5622, PLX73086, or the control chow ( n = 4–5 per group). k Quantification of the number of granulo-myelomonocytic cells at the lesion epicenter at 7 and 14 dpi in Cx3cr1 creER :: R26-TdT :: LysM -eGFP mice treated with either PLX5622, PLX73086, or the control diet ( n = 4–5 mice per group/time point). For all injured mice, treatment was initiated 3 weeks before SCI and continued until sacrifice. Data are expressed as mean ± SEM. ** p < 0.01, *** p < 0.001, **** p < 0.0001, PLX5622 or 1 dpi compared to the control group; and && p < 0.01, &&&& p < 0.0001, PLX5622 compared with the PLX73086 group. Statistical analysis was performed using a one-way ( d – g, i , j ) or two-way ( k ) ANOVA followed by a Bonferroni’s post hoc test. Scale bar: ( a – c , in c ) 200 µm
Fitc Conjugates Lectins, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/us10273313-556-6-17?v=Carl+Zeiss
Average 90 stars, based on 1 article reviews
fitc-conjugates lectins - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AnaSpec fitc-conjugated maackia amurensis lectin mal-i
The CSF1R inhibitor PLX5622, but not PLX73086, crosses the blood–spinal cord barrier to deplete virtually all microglia. a – c Representative confocal images of CD11b and P2ry12 immunostainings showing the almost complete elimination of microglia in the spinal cord of naïve (uninjured) C57BL/6 mice after treatment with the CSF1R inhibitor PLX5622 compared to those fed PLX73086 or the control diet. Mice were killed after 21 days of treatment. d – h Quantification of microglia in the spinal cord of uninjured C57BL/6 mice treated with PLX5622, PLX73086 or the control diet ( d ), as well as at the lesion epicenter in Cx3cr1 creER :: R26 - TdT mice killed at 1 ( e ), 7 ( f ), and 14 ( g ) days post-injury (dpi) ( n = 4–5 mice per group/time point). i Quantification of the proportional area of spinal cord tissue permeable to <t>FITC-conjugated</t> <t>lectin</t> injected intravenously prior to tissue fixation. j Quantification of Ly6G + neutrophils at the lesion epicenter at day 1 post-SCI in mice treated with either PLX5622, PLX73086, or the control chow ( n = 4–5 per group). k Quantification of the number of granulo-myelomonocytic cells at the lesion epicenter at 7 and 14 dpi in Cx3cr1 creER :: R26-TdT :: LysM -eGFP mice treated with either PLX5622, PLX73086, or the control diet ( n = 4–5 mice per group/time point). For all injured mice, treatment was initiated 3 weeks before SCI and continued until sacrifice. Data are expressed as mean ± SEM. ** p < 0.01, *** p < 0.001, **** p < 0.0001, PLX5622 or 1 dpi compared to the control group; and && p < 0.01, &&&& p < 0.0001, PLX5622 compared with the PLX73086 group. Statistical analysis was performed using a one-way ( d – g, i , j ) or two-way ( k ) ANOVA followed by a Bonferroni’s post hoc test. Scale bar: ( a – c , in c ) 200 µm
Fitc Conjugated Maackia Amurensis Lectin Mal I, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/10__1128_slash_jvi__00716___14-106-32-38?v=AnaSpec
Average 90 stars, based on 1 article reviews
fitc-conjugated maackia amurensis lectin mal-i - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
EY Laboratories fitc-conjugated maackia amurensis agglutinin (maa) lectin
The CSF1R inhibitor PLX5622, but not PLX73086, crosses the blood–spinal cord barrier to deplete virtually all microglia. a – c Representative confocal images of CD11b and P2ry12 immunostainings showing the almost complete elimination of microglia in the spinal cord of naïve (uninjured) C57BL/6 mice after treatment with the CSF1R inhibitor PLX5622 compared to those fed PLX73086 or the control diet. Mice were killed after 21 days of treatment. d – h Quantification of microglia in the spinal cord of uninjured C57BL/6 mice treated with PLX5622, PLX73086 or the control diet ( d ), as well as at the lesion epicenter in Cx3cr1 creER :: R26 - TdT mice killed at 1 ( e ), 7 ( f ), and 14 ( g ) days post-injury (dpi) ( n = 4–5 mice per group/time point). i Quantification of the proportional area of spinal cord tissue permeable to <t>FITC-conjugated</t> <t>lectin</t> injected intravenously prior to tissue fixation. j Quantification of Ly6G + neutrophils at the lesion epicenter at day 1 post-SCI in mice treated with either PLX5622, PLX73086, or the control chow ( n = 4–5 per group). k Quantification of the number of granulo-myelomonocytic cells at the lesion epicenter at 7 and 14 dpi in Cx3cr1 creER :: R26-TdT :: LysM -eGFP mice treated with either PLX5622, PLX73086, or the control diet ( n = 4–5 mice per group/time point). For all injured mice, treatment was initiated 3 weeks before SCI and continued until sacrifice. Data are expressed as mean ± SEM. ** p < 0.01, *** p < 0.001, **** p < 0.0001, PLX5622 or 1 dpi compared to the control group; and && p < 0.01, &&&& p < 0.0001, PLX5622 compared with the PLX73086 group. Statistical analysis was performed using a one-way ( d – g, i , j ) or two-way ( k ) ANOVA followed by a Bonferroni’s post hoc test. Scale bar: ( a – c , in c ) 200 µm
Fitc Conjugated Maackia Amurensis Agglutinin (Maa) Lectin, supplied by EY Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/10__1074_slash_mcp__m112__017558-30-21-29?v=EY+Laboratories
Average 90 stars, based on 1 article reviews
fitc-conjugated maackia amurensis agglutinin (maa) lectin - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Merck KGaA lectin-fitc conjugate l4895
The CSF1R inhibitor PLX5622, but not PLX73086, crosses the blood–spinal cord barrier to deplete virtually all microglia. a – c Representative confocal images of CD11b and P2ry12 immunostainings showing the almost complete elimination of microglia in the spinal cord of naïve (uninjured) C57BL/6 mice after treatment with the CSF1R inhibitor PLX5622 compared to those fed PLX73086 or the control diet. Mice were killed after 21 days of treatment. d – h Quantification of microglia in the spinal cord of uninjured C57BL/6 mice treated with PLX5622, PLX73086 or the control diet ( d ), as well as at the lesion epicenter in Cx3cr1 creER :: R26 - TdT mice killed at 1 ( e ), 7 ( f ), and 14 ( g ) days post-injury (dpi) ( n = 4–5 mice per group/time point). i Quantification of the proportional area of spinal cord tissue permeable to <t>FITC-conjugated</t> <t>lectin</t> injected intravenously prior to tissue fixation. j Quantification of Ly6G + neutrophils at the lesion epicenter at day 1 post-SCI in mice treated with either PLX5622, PLX73086, or the control chow ( n = 4–5 per group). k Quantification of the number of granulo-myelomonocytic cells at the lesion epicenter at 7 and 14 dpi in Cx3cr1 creER :: R26-TdT :: LysM -eGFP mice treated with either PLX5622, PLX73086, or the control diet ( n = 4–5 mice per group/time point). For all injured mice, treatment was initiated 3 weeks before SCI and continued until sacrifice. Data are expressed as mean ± SEM. ** p < 0.01, *** p < 0.001, **** p < 0.0001, PLX5622 or 1 dpi compared to the control group; and && p < 0.01, &&&& p < 0.0001, PLX5622 compared with the PLX73086 group. Statistical analysis was performed using a one-way ( d – g, i , j ) or two-way ( k ) ANOVA followed by a Bonferroni’s post hoc test. Scale bar: ( a – c , in c ) 200 µm
Lectin Fitc Conjugate L4895, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/pm33951475-379-29-36?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
lectin-fitc conjugate l4895 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
EY Laboratories phaseolus vulgaris leucoagglutinin pha-l
Carbohydrate specificities of the 16 lectins used for lectin microarray.
Phaseolus Vulgaris Leucoagglutinin Pha L, supplied by EY Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/pmc02866009-7-4-10?v=EY+Laboratories
Average 90 stars, based on 1 article reviews
phaseolus vulgaris leucoagglutinin pha-l - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ImmunoTools fitc-conjugated lectin from narcissus pseudonarcissus
Carbohydrate specificities of the 16 lectins used for lectin microarray.
Fitc Conjugated Lectin From Narcissus Pseudonarcissus, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/pmc04557675-73-9-11?v=ImmunoTools
Average 90 stars, based on 1 article reviews
fitc-conjugated lectin from narcissus pseudonarcissus - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
EY Laboratories tritc-labelled hippeastrum hybrid lectin
Carbohydrate specificities of the 16 lectins used for lectin microarray.
Tritc Labelled Hippeastrum Hybrid Lectin, supplied by EY Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/10__1128_slash_aem__00700___18-197-29-35?v=EY+Laboratories
Average 90 stars, based on 1 article reviews
tritc-labelled hippeastrum hybrid lectin - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Cosmo Bio USA fitc-conjugated lectin from phaseolus vulgaris pha
Carbohydrate specificities of the 16 lectins used for lectin microarray.
Fitc Conjugated Lectin From Phaseolus Vulgaris Pha, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/pmc05603507-128-11-14?v=Cosmo+Bio+USA
Average 90 stars, based on 1 article reviews
fitc-conjugated lectin from phaseolus vulgaris pha - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lectinity Holding Inc so4-3-galactose-polyacrylamide
Carbohydrate specificities of the 16 lectins used for lectin microarray.
So4 3 Galactose Polyacrylamide, supplied by Lectinity Holding Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/pm20610655-76-12-18?v=Lectinity+Holding+Inc
Average 90 stars, based on 1 article reviews
so4-3-galactose-polyacrylamide - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Cayman Chemical fitc-labeled rabbit iggs conjugated latex beads
Carbohydrate specificities of the 16 lectins used for lectin microarray.
Fitc Labeled Rabbit Iggs Conjugated Latex Beads, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/bio_rxiv__2021__01__19__427361-279-3-16?v=Cayman+Chemical
Average 90 stars, based on 1 article reviews
fitc-labeled rabbit iggs conjugated latex beads - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
EY Laboratories fluorescein isothiocyanate-conjugated concanavalin
Carbohydrate specificities of the 16 lectins used for lectin microarray.
Fluorescein Isothiocyanate Conjugated Concanavalin, supplied by EY Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+lectins/pmc02719324-243-0-8?v=EY+Laboratories
Average 90 stars, based on 1 article reviews
fluorescein isothiocyanate-conjugated concanavalin - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


The CSF1R inhibitor PLX5622, but not PLX73086, crosses the blood–spinal cord barrier to deplete virtually all microglia. a – c Representative confocal images of CD11b and P2ry12 immunostainings showing the almost complete elimination of microglia in the spinal cord of naïve (uninjured) C57BL/6 mice after treatment with the CSF1R inhibitor PLX5622 compared to those fed PLX73086 or the control diet. Mice were killed after 21 days of treatment. d – h Quantification of microglia in the spinal cord of uninjured C57BL/6 mice treated with PLX5622, PLX73086 or the control diet ( d ), as well as at the lesion epicenter in Cx3cr1 creER :: R26 - TdT mice killed at 1 ( e ), 7 ( f ), and 14 ( g ) days post-injury (dpi) ( n = 4–5 mice per group/time point). i Quantification of the proportional area of spinal cord tissue permeable to FITC-conjugated lectin injected intravenously prior to tissue fixation. j Quantification of Ly6G + neutrophils at the lesion epicenter at day 1 post-SCI in mice treated with either PLX5622, PLX73086, or the control chow ( n = 4–5 per group). k Quantification of the number of granulo-myelomonocytic cells at the lesion epicenter at 7 and 14 dpi in Cx3cr1 creER :: R26-TdT :: LysM -eGFP mice treated with either PLX5622, PLX73086, or the control diet ( n = 4–5 mice per group/time point). For all injured mice, treatment was initiated 3 weeks before SCI and continued until sacrifice. Data are expressed as mean ± SEM. ** p < 0.01, *** p < 0.001, **** p < 0.0001, PLX5622 or 1 dpi compared to the control group; and && p < 0.01, &&&& p < 0.0001, PLX5622 compared with the PLX73086 group. Statistical analysis was performed using a one-way ( d – g, i , j ) or two-way ( k ) ANOVA followed by a Bonferroni’s post hoc test. Scale bar: ( a – c , in c ) 200 µm

Journal: Nature Communications

Article Title: Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury

doi: 10.1038/s41467-019-08446-0

Figure Lengend Snippet: The CSF1R inhibitor PLX5622, but not PLX73086, crosses the blood–spinal cord barrier to deplete virtually all microglia. a – c Representative confocal images of CD11b and P2ry12 immunostainings showing the almost complete elimination of microglia in the spinal cord of naïve (uninjured) C57BL/6 mice after treatment with the CSF1R inhibitor PLX5622 compared to those fed PLX73086 or the control diet. Mice were killed after 21 days of treatment. d – h Quantification of microglia in the spinal cord of uninjured C57BL/6 mice treated with PLX5622, PLX73086 or the control diet ( d ), as well as at the lesion epicenter in Cx3cr1 creER :: R26 - TdT mice killed at 1 ( e ), 7 ( f ), and 14 ( g ) days post-injury (dpi) ( n = 4–5 mice per group/time point). i Quantification of the proportional area of spinal cord tissue permeable to FITC-conjugated lectin injected intravenously prior to tissue fixation. j Quantification of Ly6G + neutrophils at the lesion epicenter at day 1 post-SCI in mice treated with either PLX5622, PLX73086, or the control chow ( n = 4–5 per group). k Quantification of the number of granulo-myelomonocytic cells at the lesion epicenter at 7 and 14 dpi in Cx3cr1 creER :: R26-TdT :: LysM -eGFP mice treated with either PLX5622, PLX73086, or the control diet ( n = 4–5 mice per group/time point). For all injured mice, treatment was initiated 3 weeks before SCI and continued until sacrifice. Data are expressed as mean ± SEM. ** p < 0.01, *** p < 0.001, **** p < 0.0001, PLX5622 or 1 dpi compared to the control group; and && p < 0.01, &&&& p < 0.0001, PLX5622 compared with the PLX73086 group. Statistical analysis was performed using a one-way ( d – g, i , j ) or two-way ( k ) ANOVA followed by a Bonferroni’s post hoc test. Scale bar: ( a – c , in c ) 200 µm

Article Snippet: For the quantification of the BSCB permeability, the proportional area of tissue stained with the FITC-LEA lectin within the entire coronal section at the lesion epicenter was measured using images taken at ×20 magnification with the Zeiss Slide Scanner Axio Scan.Z1.

Techniques: Injection

Carbohydrate specificities of the 16 lectins used for lectin microarray.

Journal:

Article Title: Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach

doi: 10.1021/pr100012p

Figure Lengend Snippet: Carbohydrate specificities of the 16 lectins used for lectin microarray.

Article Snippet: Phaseolus vulgaris leucoagglutinin , PHA-L , Galβ (1–4)GlcNAcβ (1–6)Man , EY Laboratories Inc..

Techniques: Microarray, Plasmid Preparation